Drugs like aspirin and clopidogrel (Plavix, NYSE:BMY) prevent platelets from clumping together into a clot.
Bristol-Myers Squibb ( BMY - news - people ) under the Taxol name.
FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.
Bristol-Myers Squibb (59, BMY), whose shares have tumbled 20% since December, also faces problems with new generic competitors.
Bristol-Myers (nyse: BMY - news - people ) has a DPP-4 inhibitor in mid-stage trials.
Bristol-Myers Squibb (nyse: BMY - news - people ) and GlaxoSmithkline are testing similar drugs.
In the end, this development may be positive for Bristol Myers (BMY) which has a large oncology franchise.
FORBES: FDA Hits Avastin, Says Best Selling Breast Cancer Drug Does Not Work
Pravachol, a Bristol-Myers Squibb (nyse: BMY - news - people) drug, takes most of the leftovers.
Pravachol, made by Bristol-Myers Squibb (nyse: BMY - news - people ), is the next biggest.
In the past three years, Bristol (nyse: BMY - news - people ) shares have dropped 55%.
Other competitors in the healthcare sector include: PDL BioPharma Inc. (PDLI), Abbott Laboratories (ABT), and Bristol Myers Squibb (BMY).
Bristol-Myers Squibb ( BMY - news - people ) sells a drug called Sprycel that competes with Tasigna.
Barrow dumps stocks when they get too expensive, as Bristol-Myers Squibb (nyse: BMY - news - people) did.
Pargluva, from Bristol-Myers Squibb (nyse: BMY - news - people ), was never approved after such an analysis.
Such stocks include Merck(MRK), yielding 4.14%, Chevron Corp, (CVX) yielding 3.22%, Bristol-Myer, (BMY), yielding 4.19%, DuPont, (DD), yielding 3.77%, or Verizon Communications(VZ) paying 4.71%.
FORBES: Buy the Shares of Companies Likely to Buyback Their Stock over the Next 10 Years
Worse, the problem lies in Bristol-Myers' (nyse: BMY - news - people ) core business: Selling prescription drugs.
Only one, Bristol-Myers Squibb 's (nyse: BMY - news - people ) Tequin, has been widely tested in children.
Sanofi now sells Ambien on its own, but Bristol-Myers Squibb (nyse: BMY - news - people ) markets Plavix.
Bristol-Myers Squibb (nyse: BMY - news - people) has gotten rid of both its orthopedics and beauty products divisions.
And a committee recommended approval for Pargluva, a diabetes drug from Bristol-Myers Squibb (nyse: BMY - news - people ).
Abbott Laboratories (ABT) is down 12.4%, Bristol Myers (BMY) is down 14.8%, Eli Lilly (LLY) is down 14.6%, and Merck (MRK) is down 10.7%.
One of these studies was not funded by Pfizer but by rival Bristol-Myers Squibb (nyse: BMY - news - people ).
Bristol-Myers (nasdaq: BMY - news - people ) had been hoping UFT would help fill a hole in its cancer pipeline.
Some investors have been reaching for pharmaceutical stocks like Pfizer (NYSE:PFE), Bristol-Myers Squib (NYSE:BMY), and Abbot Laboratories (NYSE:ABT) that pay close to 5 percent dividend.
Abilify, a schizophrenia medicine from Bristol-Myers Squibb (nyse: BMY - news - people ) and Japan's Otsuka, is also gaining ground fast.
It would be best for long-term investors and the drug industry if Bristol (nyse: BMY - news - people ) doesn't sell out.
Bristol (nyse: BMY - news - people ) gave no guidance about how low it would restate earnings for 2000, 2001 and 2002.
Furthermore, trading at 2.14x sales per share, BMY looks like a deal compared to the historically normal range of 2.05x to 3.02x times sales per share.
Two new "super Gleevec" drugs are nearing the market--dasatinib from Bristol-Myers Squibb (nyse: BMY - news - people ) and nilotinib from Novartis.
One of the companies that consistently missed its earlier consensus numbers is pharmaceuticals giant Bristol-Myers Squibb (nyse: BMY - news - people ).
Bristol (nyse: BMY - news - people ) spokeswoman Bonnie Jacobs confirmed the SEC inquiry and said the New York-based company is cooperating fully.
应用推荐